Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation and application of a cell membrane biomimetic lipoprotein targeting nano drug delivery system

A nano-drug delivery system and cell membrane technology, which is applied in the preparation and application of cell membrane biomimetic lipoprotein-targeted nano-drug delivery system, can solve limitations and other problems, and achieve the effects of increasing directional accumulation, increasing therapeutic effect, and improving bioavailability

Active Publication Date: 2021-05-07
CHINA PHARM UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although compared with infection, trauma and other diseases, the inflammatory response in adipose tissue is mild and localized, but it can still cause the infiltration of immune cells such as macrophages

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation and application of a cell membrane biomimetic lipoprotein targeting nano drug delivery system
  • Preparation and application of a cell membrane biomimetic lipoprotein targeting nano drug delivery system
  • Preparation and application of a cell membrane biomimetic lipoprotein targeting nano drug delivery system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-6

[0041] 1. Preparation of recombinant high-density lipoprotein drug-loaded core (rHDL / Rosi&Sild)

[0042] Weigh a certain amount of phospholipids, cholesterol, rosiglitazone and sildenafil, mix and dissolve them in an organic solvent, spin-evaporate under reduced pressure in a water bath at 37°C to form a thin film, then dry in vacuum overnight to remove excess organic solvent, and then add Appropriate amount of pure water was completely hydrated in a 40°C water bath, and ultrasonically dispersed to obtain an opalescent nanosuspension; add a certain amount of ApoA-I phosphate buffer (PBS, pH 7.4) and stir overnight, and deionized water Dialyzed for 12 hours to remove free ApoA-I to obtain the recombinant high-density lipoprotein drug-loaded inner core. The coumarin and the double drug were added together, and the above steps were repeated to obtain fluorescently labeled rHDL / Rosi&Sild.

[0043] Wherein the preparation process conditions of recombinant high-density lipoprotein ...

Embodiment 7-10

[0048] 2. Extraction of macrophage membrane (Ma)

[0049] The culture medium in the macrophage culture flask was discarded, the macrophages were blown off after washing with PBS solution (pH 7.4) for 3 times, and the supernatant was removed by centrifugation at 1000 rpm. Add cell lysate (1mM sodium bicarbonate, 0.2mM ethylenediaminetetraacetic acid and 1mM serine protease inhibitor) to the pellet, lyse at 4°C overnight, then sonicate the probe for 10min, centrifuge at 3200×g for 5-10min, discard the pellet, and The supernatant was centrifuged at 4°C at 18,000×g for 45-60 min, discarded, and the pellet was resuspended in PBS solution (pH 7.4) to obtain a macrophage membrane suspension. The DiI PBS solution was added to the prepared macrophage membrane mixture and incubated for 35 minutes, and dialyzed against deionized water for 12 hours to obtain a fluorescently labeled macrophage membrane suspension.

[0050] Wherein, the extraction process conditions of macrophage membrane ...

example 16-19

[0060] 4. Preparation of P3 peptide-modified cell membrane biomimetic recombinant high-density lipoprotein drug-loaded nanoparticles (P3-Ma / rHDL / Rosi&Sild)

[0061] The PBS solution (pH 7.4) of the P3 peptide-stearic acid conjugate was mixed with the cell membrane biomimetic recombinant high-density lipoprotein drug-loaded nanoparticle suspension in a certain proportion, incubated at 37°C for 60 minutes, and then dialyzed with deionized water for 12 hours. The free peptide is removed to obtain the P3 peptide-modified cell membrane biomimetic recombinant high-density lipoprotein drug-loaded nanoparticle. .

[0062] Among them, the preparation process conditions of the P3 peptide-modified cell membrane biomimetic recombinant high-density lipoprotein drug-loaded nanoparticles in Examples 16-19 are shown in Table 4:

[0063] Table 4 Process conditions for the preparation of P3 peptide-modified cell membrane biomimetic recombinant high-density lipoprotein drug-loaded nanoparticles...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of pharmaceutical preparations, and relates to the preparation and application of a cell membrane biomimetic lipoprotein targeting nano drug delivery system. This patent uses recombinant high-density lipoprotein (rHDL) in the lipoprotein family to embed anti-obesity drugs to form a drug-loaded core, and P3 peptide to modify cell membranes to form a bionic shell, and to construct a biomimetic targeting nanoparticle for obesity treatment. The characteristics of the particles are as follows: (1) The cell membrane bionic shell modified by P3 peptide has good biocompatibility and adipose tissue targeting, which can reduce the opsonization and phagocytosis of nanoparticles by the immune system, prolong the circulation time of drugs in the body, and increase the concentration of drugs. Accumulation in adipose tissue; (2) rHDL core drug carrier has high safety and good carrying capacity, can load fat-soluble drugs through core embedding, and can be completely biodegraded without triggering immune response; (3) Anti-obesity drugs can stimulate adipose tissue angiogenesis and increase browning of white adipose tissue, and the mechanism can be used synergistically to treat obesity.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and relates to the preparation and application of a cell membrane biomimetic lipoprotein targeting nano drug delivery system. Background technique [0002] Obesity is caused by the excessive accumulation of fat in the body due to the imbalance between energy absorption and energy consumption. It is a symptom of metabolic syndrome, type II diabetes (T 2 DM), cardiovascular disease, cancer and other chronic diseases, seriously affecting human life expectancy. At present, in addition to diet and exercise, clinical treatments for weight loss can be divided into two types, one is surgical treatment, such as liposuction and gastric bypass surgery, and the other is drug treatment, such as orlistat , Lorcaserin hydrochloride, etc. However, both treatment methods have side effects in varying degrees: surgical treatment has poor patient compliance, while drug treatment, such as orlistat, has se...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/42A61K47/64A61K47/46A61K9/51A61K31/519A61K31/4439A61P3/04
CPCA61K9/5169A61K9/5176A61K31/4439A61K31/519A61K47/64A61P3/04A61K2300/00
Inventor 王伟王婷婷谢梦颖
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com